findmyKOL
Clinical trialNCT02396459Active, not recruitingPhase 2Interventional

Triac Trial II in MCT8 Deficiency Patients

SponsorRare Thyroid Therapeutics International ABEnrollment22Allan-Herndon-Dudley Syndrome
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Andrew Bauer, MD

    Children's Hospital of Philadelphia

    Principal Investigator
  • Heiko Krude

    Charité - Universitätsmedizin Berlin Institut fur experimental paediatrische endokrinologie

    Principal Investigator
  • Jan Lebl

    Charles University and Motol University Hospital

    Principal Investigator
  • Kristina Sjöblom Nygren, MD

    Rare Thyroid Therapeutics International AB

    Study Director
  • Lindsey Nicol

    Oregon Health& Science University (OHSU) Doernbecher Childrens Hospital

    Principal Investigator
  • W.E. Visser, MD, PhD

    Erasmus Medical Center

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Czechia
  • Charles University and Motol University Hospital; the Department of Peadiatrics of the 2nd Faculty of Medicine

    Prague, Czechia

Germany
  • Charité - Universitätsmedizin Berlin Institut Fur Experimental Paediatrische Endokrinologie

    Berlin, Germany

Netherlands
  • Erasmus Mc

    Rotterdam, Netherlands

United States
  • Oregon Health & Science University (ohsu) Doernbecher Childrens Hospital

    Portland, Oregon, United States

  • Children'S Hospital of Philadelphia

    Philadelphia, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
7 Dec 2020
Primary completion
18 Jul 2027
Completion
18 Aug 2027
Last update posted
20 Feb 2026
Registered enrollment
22
Registry id
NCT02396459

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.